title: [The condition of lipid peroxidation in mice and the effect of fullerene C60 during immune response].
abstract: The aim of this study was to assess the influence of fullerene C60 on lipid peroxidation (POL) and antioxidant protection during the induction of the immune response to heteroantigen. Balb/c mice were immunized intraperitoneal (i.p.) with sheep erythrocytes for the primary immunization. Water dispersion of fullerene C60 was injected i.p. once at the dose 50 ng to mice on first, third and sixth days after immunization. During immune response, the increment ofmalonic dialdehide (MDA) was enhanced in liver, kidneys and heart tissues. Fullerene C60 induced POL during the latent phase of immune response, but inhibited this process during progression of immune response. Activities of superoxide dismutase (SOD) and catalase in liver and spleen tissues were induced after injection of fullerene C60 to intact mice. After immunization, high level of activity of antioxidant enzymes and low level of organs mass factor were determined. Injection of fullerene C60 reduced the activities of SOD and catalase in spleen tissues. The results of our study indicate that fullerene C60 can display positive effect on POL processes and antioxidant enzymes activity which is probably due to membrane's stabilization action or the ability of fullerene C60 to bind free radicals independently.
authors.forename: L E
authors.initials: LE
authors.lastname: Vesnina
authors.forename: T V
authors.initials: TV
authors.lastname: Mamontova
authors.forename: M V
authors.initials: MV
authors.lastname: Mykytiuk
authors.forename: L O
authors.initials: LO
authors.lastname: Kutsenko
authors.forename: N O
authors.initials: NO
authors.lastname: Bobrova
authors.forename: N L
authors.initials: NL
authors.lastname: Kutsenko
authors.forename: I P
authors.initials: IP
authors.lastname: Kaĭdashev
mesh_terms: D000818:Animals; D015478:Antigens, Heterophile / Q000008:administration & dosage / Q000276:immunology*; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002374:Catalase / Q000378:metabolism; D004912:Erythrocytes / Q000276:immunology*; D005609:Free Radicals / Q000037:antagonists & inhibitors / Q000378:metabolism; D037741:Fullerenes / Q000008:administration & dosage / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007668:Kidney / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects* / Q000276:immunology; D008099:Liver / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D012756:Sheep; D013154:Spleen / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D015478:Antigens, Heterophile; D000975:Antioxidants; D005609:Free Radicals; D037741:Fullerenes; D008315:Malondialdehyde; D002374:Catalase; D013482:Superoxide Dismutase; C069837:fullerene C60